Platform-based Process Analytical Technologies (PATs) Built for Modern Bioprocesses
Accelerate and simplify "common" analytical measurements carried out by conventional mass spec workflows.
Develop better, faster assays to telescope the drug discovery process and get advanced therapies to market faster.
Provide predictive process control for reduced in-process failures of complex and costly biopharma processes.
"It’s not unusual for [Cell and Gene Therapy] companies to admit that they don’t know where to begin with picking a CQA [Critical Quality Attribute]."
“Knowing intermittent steps in the whole process, and the ability to measure dynamically, is an unmet need!”
We're currently working with Pharma Co's and Biotechs to accelerate their Mass Spec workflows, and with Advanced Therapies Developers to enable better cell-state characterization.
If we can help accelerate your Mass Spec workflow or help measure critical biomarkers and cell-state for your iPSC and MSC research, please reach out!